Agilis Biotherapeutics has been awarded a Cooperative Research and Development Agreement by National Center for Accelerating Translational Sciences (NCATS) to facilitate development of the company ...

Agilis’ gene therapy program has been developed in collaboration with National Taiwan University and the U.S. National Institutes of Health’s National Center for Advancing Translational ...

We believe this program represents an important catalyst for Agilis and an important validation of the potential for gene therapy in treating rare CNS disorders. Pending successful completion of a ...